Lilly confirms date and conference call for fourth-quarter 2025 financial results announcement
Eli Lilly (NYSE: LLY) will report its fourth-quarter 2025 financial results on February 4, 2026.
Rhea-AI Summary
Eli Lilly (NYSE: LLY) will report its fourth-quarter 2025 financial results on February 4, 2026. A conference call with the investment community and media will be held the same day beginning at 10 a.m. Eastern. Investors, media and the public can access a live webcast via the company's investor website, and a replay will be posted after the call.
Positive
- None.
Negative
- None.
Details
News Market Reaction – LLY
In the Jan 21 session, LLY gained 3.58%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Q4 2025 earnings date
- February 4, 2026
- Scheduled announcement of Q4 2025 financial results
- Conference call time
- 10:00 a.m. Eastern time
- Start time for Q4 2025 results call on February 4, 2026
- Webcast access
- https://investor.lilly.com/webcasts-and-presentations
- Live and replay webcast location for the conference call
Historical Context
-
Highlight of Lilly-valued collaboration tied to Aktis Oncology IPO.
-
Phase 3b trial showed superior efficacy for Taltz and Zepbound combo.
-
Agreement to acquire Ventyx Biosciences in all-cash deal.
-
Phase 3 orforglipron trial met primary and key secondary endpoints.
-
Announcement of participation in J.P. Morgan Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The conference call will begin at 10 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-fourth-quarter-2025-financial-results-announcement-302666076.html
SOURCE Eli Lilly and Company
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.